Deuterated Atazanivir-D3-3
Modify Date: 2024-02-26 09:08:14
Deuterated Atazanivir-D3-3 structure
|
Common Name | Deuterated Atazanivir-D3-3 | ||
|---|---|---|---|---|
| CAS Number | 1092540-52-7 | Molecular Weight | 722.97 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C38H34D18N6O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Deuterated Atazanivir-D3-3Atazanavir-d18 is the d18 labled Atazanavir (HY-17367). Atazanavir is a selective HIV-1 protease inhibitor[1]. |
| Name | methyl N-[(2S)-4,4,4-trideuterio-1-[[(2S,3S)-3-hydroxy-1-phenyl-4-[(4-pyridin-2-ylphenyl)methyl-[[(2S)-4,4,4-trideuterio-2-(methoxycarbonylamino)-3,3-bis(trideuteriomethyl)butanoyl]amino]amino]butan-2-yl]amino]-1-oxo-3,3-bis(trideuteriomethyl)butan-2-yl]c |
|---|---|
| Synonym | More Synonyms |
| Description | Atazanavir-d18 is the d18 labled Atazanavir (HY-17367). Atazanavir is a selective HIV-1 protease inhibitor[1]. |
|---|---|
| Related Catalog | |
| Target |
HIV-1 |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C38H34D18N6O7 |
|---|---|
| Molecular Weight | 722.97 |
| Exact Mass | 722.50300 |
| PSA | 185.18000 |
| LogP | 6.30100 |
| Storage condition | -20℃ |
| 1,14-dichloro-5,5,10,10-tetraphenyl-5,10-distannatetradecane |
| Stannane,1,4-butanediylbis[(4-chlorobutyl)diphenyl |
| 1,14-dimethyl (3S,8S,9S,12S)-3,12-bis[(1,1-dimethylethyl)-d9]-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioate |
| 1,14-dimethyl (3S,8S,9S,12S)-3-(1,1-dimethylethyl)-12-[(1,1-dimethylethyl)-d9]-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioate |
| Atazanavir-d18 |